Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 [Phase 2]

View source ↗

Summary

Phase 2 PSP trial platform update describing Regimen B with LM11A-31, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LM11A-31 (LM11A-31)

Snippet

Sponsor: Adam Boxer | Conditions: PSP - Progressive Supranuclear Palsy | Phase 2 | Status: NOT_YET_RECRUITING